Public announcement
The “Guarantors of EQIPD” officially announced their launch with a public press release. The society is registered since December 2021 and became fully operational now.
The “Guarantors of EQIPD” officially announced their launch with a public press release. The society is registered since December 2021 and became fully operational now.
The first Newsletter by the EQIPD consortium can be found HERE.
The EQIPD project was presented at the PreNeuroscience 2018 Seminar and Networking event that took place on 2 November 2018 inconjunction with the Society for Neuroscience’s (SfN) annual meeting in San Diego, California, USA, to create awareness in the USA as well – Download our 2nd newsletter to see more updates and news! Read the…
The Research Transparency Tool was developed by the EQIPD Consortium Taskforce and implemented online with support from a SBIR award from the NIH: https://public-funding-tool.paasp.net/survey The tool creates a “snapshot” of the environment in which research is conducted and is meant to help funders and applicants align on relevant quality expectations. More information in the EQIPD…
Check out the updates on the outcome of the Alzheimer systematic review, the EQIPD brainstorming session at ECNP, and more in the newest version of our newsletter! Read the Newsletter here.
On October 10, 2022, #EQIPD will lead a discussion on how to help funders and grant applicants align on research rigor expectations and avoid funding of research of unknown quality. Objectives of the meeting are to: Review lessons learned from the US and German publicly funded programs that focused directly or indirectly on decision-enabling research…
Our book on quality in preclinical research, including many articles from authors within the EQIPD consortium, has just been published: Bespalov A, Michel MC, Steckler T (eds) Handbook of Experimental Pharmacology – Good Research Practice in Non-Clinical Pharmacology and Biomedicine, Springer Open, Cham, Switzerland. ISBN 978-3-030-33655-4, eBook ISBN 978-3-030-33656-1 (2020). Access the book HERE.